ABVC BioPharma Inc (ABVC)
1.11
+0.05
(+4.72%)
USD |
NASDAQ |
May 08, 16:00
1.15
+0.04
(+3.60%)
After-Hours: 17:34
ABVC BioPharma Free Cash Flow: -4.257M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -4.257M |
September 30, 2023 | -4.239M |
June 30, 2023 | -3.377M |
March 31, 2023 | -5.928M |
December 31, 2022 | -7.518M |
September 30, 2022 | -9.582M |
June 30, 2022 | -11.30M |
March 31, 2022 | -9.290M |
December 31, 2021 | -7.615M |
September 30, 2021 | -7.279M |
June 30, 2021 | -5.374M |
March 31, 2021 | -5.346M |
December 31, 2020 | -4.564M |
September 30, 2020 | -3.872M |
June 30, 2020 | -3.785M |
March 31, 2020 | -3.166M |
December 31, 2019 | -3.134M |
September 30, 2019 | -1.101M |
June 30, 2019 | -1.069M |
March 31, 2019 | -0.7042M |
December 31, 2018 | -0.6302M |
September 30, 2018 | -1.492M |
June 30, 2018 | -1.470M |
March 31, 2018 | -1.899M |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | -1.599M |
June 30, 2017 | -1.487M |
March 31, 2017 | -4.133M |
December 31, 2016 | -2.825M |
September 30, 2016 | -3.475M |
June 30, 2016 | -3.262M |
March 31, 2016 | -0.4255M |
December 31, 2015 | -0.8709M |
September 30, 2015 | 0.0034M |
June 30, 2015 | 0.0035M |
March 31, 2015 | 0.0012M |
December 31, 2014 | 0.0012M |
September 30, 2014 | 0.0012M |
June 30, 2014 | -0.0001M |
March 31, 2014 | -0.0002M |
December 31, 2013 | -0.0014M |
September 30, 2013 | -0.0378M |
June 30, 2013 | -0.1319M |
March 31, 2013 | -0.3723M |
December 31, 2012 | -0.5864M |
September 30, 2012 | -0.9347M |
June 30, 2012 | -1.142M |
March 31, 2012 | -1.257M |
December 31, 2011 | -1.862M |
September 30, 2011 | -1.632M |
Free Cash Flow Range, Past 5 Years
-11.30M
Minimum
Jun 2022
-1.069M
Maximum
Jun 2019
-5.357M
Average
-4.564M
Median
Dec 2020
Free Cash Flow Benchmarks
NeuBase Therapeutics Inc | -14.85M |
Sutro Biopharma Inc | -115.93M |
Reviva Pharmaceuticals Holdings Inc | -28.32M |
Flora Growth Corp | -8.63M |
Journey Medical Corp | 0.24M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -0.4795M |
Cash from Investing (Quarterly) | 0.1542M |
Cash from Financing (Quarterly) | 0.0874M |
Free Cash Flow Per Share (Quarterly) | -0.0606 |
Free Cash Flow to Equity (Quarterly) | 0.5583M |
Free Cash Flow to Firm (Quarterly) | 0.6456M |
Free Cash Flow Yield | -82.54% |